{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:49:10Z","timestamp":1790124550885,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.radonc.2024.110261","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T16:30:35Z","timestamp":1711470635000},"page":"110261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Synergizing the interaction of single nucleotide polymorphisms with dosiomics features to build a dual-omics model for the prediction of radiation pneumonitis"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5756-8412","authenticated-orcid":false,"given":"Bin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110261_b0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: assessment and management","volume":"156","author":"Hanania","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.radonc.2024.110261_b0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncr.31043","article-title":"Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: a systematic analysis of the literature","volume":"124","author":"Pillai","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110261_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2018.07.027","article-title":"Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy","author":"Rossi","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110261_b0020","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1088\/1361-6560\/aa8d09","article-title":"Deep convolutional neural network with transfer learning for rectum toxicity prediction in cervical cancer radiotherapy: a feasibility study","volume":"62","author":"Zhen","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110261_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00269","article-title":"Dosiomics: extracting 3D spatial features from dose distribution to predict incidence of radiation pneumonitis","volume":"9","author":"Liang","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110261_b0030","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1002\/mp.15079","article-title":"A deep learning-based dual-omics prediction model for radiation pneumonitis","volume":"48","author":"Bin","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2021.01.049","article-title":"Dosimetric factors and radiomics features within different regions of interest in planning CT images for improving the prediction of radiation pneumonitis","volume":"110","author":"Jiang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0360-3016(01)01685-6","article-title":"Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer","volume":"51","author":"Hernando","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0050","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/j.ijrobp.2012.03.067","article-title":"Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy","volume":"84","author":"Stenmark","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2010.03.058","article-title":"An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables","volume":"80","author":"Jenkins","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0060","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.ijrobp.2010.11.079","article-title":"Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy","volume":"81","author":"Yin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0065","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ijrobp.2009.07.1675","article-title":"ATM polymorphisms are associated with risk of radiation-induced pneumonitis","volume":"77","author":"Zhang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cllc.2015.11.008","article-title":"Single nucleotide polymorphisms in CBLB, a regulator of T-cell response, predict radiation pneumonitis and outcomes after definitive radiotherapy for non-small-cell lung cancer","volume":"17","author":"Li","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110261_b0075","doi-asserted-by":"crossref","first-page":"e12402","DOI":"10.1371\/journal.pone.0012402","article-title":"Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer","volume":"5","author":"Hildebrandt","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2024.110261_b0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2014.03.001","article-title":"Genetic variants in inducible nitric oxide synthase gene are associated with the risk of radiation-induced lung injury in lung cancer patients receiving definitive thoracic radiation","volume":"111","author":"Zhang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110261_b0085","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ijrobp.2012.10.011","article-title":"Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer","volume":"85","author":"Pang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7150\/jca.20643","article-title":"GSTP1 Ile105Val polymorphism might be associated with the risk of radiation pneumonitis among lung cancer patients in Chinese population: a prospective study","volume":"9","author":"Du","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2024.110261_b0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijrobp.2012.02.021","article-title":"Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis","volume":"85","author":"Tucker","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110261_b0100","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.7150\/jca.37708","article-title":"Precise prediction of the radiation pneumonitis in lung cancer: an explorative preliminary mathematical model using genotype information","volume":"11","author":"Du","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.radonc.2024.110261_b0105","doi-asserted-by":"crossref","unstructured":"Rendle S, editor Factorization machines. 2010 IEEE International conference on data mining; 2010: IEEE.","DOI":"10.1109\/ICDM.2010.127"},{"key":"10.1016\/j.radonc.2024.110261_b0110","unstructured":"USDOHAH. S. Common Terminology Criteria for Adverse Events (CTCAE). Available from: https:\/\/ctepcancergov\/protocolDevelop ment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7 pdf. 2017."},{"key":"10.1016\/j.radonc.2024.110261_b0115","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","article-title":"Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy","volume":"27","author":"Peng","year":"2005","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.radonc.2024.110261_b0120","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110261_b0125","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1002\/cncr.33083","article-title":"A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: hoosier cancer research network LUN 14\u2013179","volume":"126","author":"Durm","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110261_b0130","article-title":"Pembrolizumab plus concurrent chemoradiation therapy in patients with unresectable, locally advanced, stage III non-small cell lung cancer: the phase 2 KEYNOTE-799 nonrandomized trial","author":"Jabbour","year":"2021","journal-title":"J Am Med Assoc Oncol"},{"key":"10.1016\/j.radonc.2024.110261_b0135","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jtho.2020.10.129","volume":"16","author":"Peters","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110261_b0140","doi-asserted-by":"crossref","unstructured":"Melissa Yan GAD, Hirva Mamdani, Vinicius Ernani, Salma K. Jabbour, Jarushka Naidoo, Borys Hrinczenko, Ticiana Leal, Lawrence Eric Feldman, Goetz H. Kloecker, Naomi Fujioka, Mary J. Fidler, Nasser H. Hanna. Consolidation nivolumab\/ipilimumab versus nivolumab following concurrent chemoradiation in patients with unresectable stage III NSCLC: A planned interim safety analysis from the BTCRC LUN 16-081 trial. Journal of Clinical Oncology. 2020;38(15 Suppl):9010.","DOI":"10.1200\/JCO.2020.38.15_suppl.9010"},{"key":"10.1016\/j.radonc.2024.110261_b0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jtho.2019.10.024","article-title":"Phase II trial of concurrent atezolizumab with chemoradiation for unresectable NSCLC","volume":"15","author":"Lin","year":"2020","journal-title":"J Thorac Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:11:16Z","timestamp":1731028276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402400183X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"alternative-id":["S016781402400183X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110261","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergizing the interaction of single nucleotide polymorphisms with dosiomics features to build a dual-omics model for the prediction of radiation pneumonitis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110261"}}